nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLC7A11—Riluzole—amyotrophic lateral sclerosis	0.801	0.884	CbGbCtD
Rosuvastatin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.105	0.116	CbGbCtD
Rosuvastatin—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00371	0.0641	CcSEcCtD
Rosuvastatin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00317	0.0548	CcSEcCtD
Rosuvastatin—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0426	CcSEcCtD
Rosuvastatin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0412	CcSEcCtD
Rosuvastatin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0331	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0315	CcSEcCtD
Rosuvastatin—Injury—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0298	CcSEcCtD
Rosuvastatin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0291	CcSEcCtD
Rosuvastatin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0247	CcSEcCtD
Rosuvastatin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0241	CcSEcCtD
Rosuvastatin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0237	CcSEcCtD
Rosuvastatin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0232	CcSEcCtD
Rosuvastatin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0228	CcSEcCtD
Rosuvastatin—SLC7A11—tongue—amyotrophic lateral sclerosis	0.00123	0.185	CbGeAlD
Rosuvastatin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00122	0.021	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0207	CcSEcCtD
Rosuvastatin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0206	CcSEcCtD
Rosuvastatin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0205	CcSEcCtD
Rosuvastatin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0201	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00116	0.02	CcSEcCtD
Rosuvastatin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0198	CcSEcCtD
Rosuvastatin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.019	CcSEcCtD
Rosuvastatin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0189	CcSEcCtD
Rosuvastatin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0188	CcSEcCtD
Rosuvastatin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00098	0.0169	CcSEcCtD
Rosuvastatin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000961	0.0166	CcSEcCtD
Rosuvastatin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000941	0.0162	CcSEcCtD
Rosuvastatin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000872	0.0151	CcSEcCtD
Rosuvastatin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000833	0.0144	CcSEcCtD
Rosuvastatin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000813	0.014	CcSEcCtD
Rosuvastatin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000813	0.014	CcSEcCtD
Rosuvastatin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000785	0.0136	CcSEcCtD
Rosuvastatin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000774	0.0134	CcSEcCtD
Rosuvastatin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000764	0.0132	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000763	0.0132	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00071	0.0123	CcSEcCtD
Rosuvastatin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000705	0.0122	CcSEcCtD
Rosuvastatin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0007	0.0121	CcSEcCtD
Rosuvastatin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000686	0.0118	CcSEcCtD
Rosuvastatin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000666	0.0115	CcSEcCtD
Rosuvastatin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000666	0.0115	CcSEcCtD
Rosuvastatin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000642	0.0111	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000637	0.011	CcSEcCtD
Rosuvastatin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000619	0.0107	CcSEcCtD
Rosuvastatin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000616	0.0106	CcSEcCtD
Rosuvastatin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000574	0.00991	CcSEcCtD
Rosuvastatin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000559	0.00965	CcSEcCtD
Rosuvastatin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000551	0.00952	CcSEcCtD
Rosuvastatin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00921	CcSEcCtD
Rosuvastatin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000515	0.0089	CcSEcCtD
Rosuvastatin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00848	CcSEcCtD
Rosuvastatin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00848	CcSEcCtD
Rosuvastatin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000488	0.00843	CcSEcCtD
Rosuvastatin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00799	CcSEcCtD
Rosuvastatin—SLC7A11—spinal cord—amyotrophic lateral sclerosis	0.000336	0.0506	CbGeAlD
Rosuvastatin—SLC7A11—nervous system—amyotrophic lateral sclerosis	0.000283	0.0426	CbGeAlD
Rosuvastatin—SLC7A11—central nervous system—amyotrophic lateral sclerosis	0.000273	0.041	CbGeAlD
Rosuvastatin—SLC7A11—cerebellum—amyotrophic lateral sclerosis	0.000266	0.0401	CbGeAlD
Rosuvastatin—HMGCR—medulla oblongata—amyotrophic lateral sclerosis	0.000234	0.0353	CbGeAlD
Rosuvastatin—SLC7A11—brain—amyotrophic lateral sclerosis	0.000216	0.0326	CbGeAlD
Rosuvastatin—HMGCR—spinal cord—amyotrophic lateral sclerosis	0.000209	0.0314	CbGeAlD
Rosuvastatin—SLCO2B1—medulla oblongata—amyotrophic lateral sclerosis	0.000198	0.0299	CbGeAlD
Rosuvastatin—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000183	0.0275	CbGeAlD
Rosuvastatin—SLCO2B1—spinal cord—amyotrophic lateral sclerosis	0.000177	0.0266	CbGeAlD
Rosuvastatin—HMGCR—nervous system—amyotrophic lateral sclerosis	0.000176	0.0265	CbGeAlD
Rosuvastatin—HMGCR—central nervous system—amyotrophic lateral sclerosis	0.000169	0.0255	CbGeAlD
Rosuvastatin—HMGCR—cerebellum—amyotrophic lateral sclerosis	0.000166	0.0249	CbGeAlD
Rosuvastatin—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000163	0.0245	CbGeAlD
Rosuvastatin—SLCO2B1—nervous system—amyotrophic lateral sclerosis	0.000149	0.0224	CbGeAlD
Rosuvastatin—SLCO2B1—central nervous system—amyotrophic lateral sclerosis	0.000144	0.0216	CbGeAlD
Rosuvastatin—SLCO2B1—cerebellum—amyotrophic lateral sclerosis	0.00014	0.0211	CbGeAlD
Rosuvastatin—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000137	0.0207	CbGeAlD
Rosuvastatin—HMGCR—brain—amyotrophic lateral sclerosis	0.000135	0.0202	CbGeAlD
Rosuvastatin—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000132	0.0199	CbGeAlD
Rosuvastatin—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000132	0.0199	CbGeAlD
Rosuvastatin—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000129	0.0194	CbGeAlD
Rosuvastatin—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000127	0.0191	CbGeAlD
Rosuvastatin—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000124	0.0187	CbGeAlD
Rosuvastatin—SLCO2B1—brain—amyotrophic lateral sclerosis	0.000114	0.0172	CbGeAlD
Rosuvastatin—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000111	0.0167	CbGeAlD
Rosuvastatin—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000106	0.0159	CbGeAlD
Rosuvastatin—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000105	0.0158	CbGeAlD
Rosuvastatin—ALB—brain—amyotrophic lateral sclerosis	0.000104	0.0157	CbGeAlD
Rosuvastatin—ABCC4—brain—amyotrophic lateral sclerosis	0.000101	0.0152	CbGeAlD
Rosuvastatin—ABCG2—cerebellum—amyotrophic lateral sclerosis	8.77e-05	0.0132	CbGeAlD
Rosuvastatin—ABCC1—brain—amyotrophic lateral sclerosis	8.61e-05	0.013	CbGeAlD
Rosuvastatin—ABCG2—brain—amyotrophic lateral sclerosis	7.13e-05	0.0107	CbGeAlD
Rosuvastatin—CYP3A4—nervous system—amyotrophic lateral sclerosis	6.5e-05	0.00977	CbGeAlD
Rosuvastatin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	6.25e-05	0.00941	CbGeAlD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.81e-05	0.00163	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.77e-05	0.00162	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.77e-05	0.00162	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.77e-05	0.00162	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.76e-05	0.00161	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.72e-05	0.0016	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.7e-05	0.00159	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.7e-05	0.00159	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.65e-05	0.00158	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—DAO—amyotrophic lateral sclerosis	4.59e-05	0.00156	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	4.55e-05	0.00154	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.53e-05	0.00154	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.53e-05	0.00154	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.52e-05	0.00153	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	4.51e-05	0.00153	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.5e-05	0.00153	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.44e-05	0.00151	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—GSR—amyotrophic lateral sclerosis	4.44e-05	0.00151	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.44e-05	0.00151	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.37e-05	0.00148	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.36e-05	0.00148	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.35e-05	0.00148	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.23e-05	0.00144	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.23e-05	0.00143	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.23e-05	0.00143	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.22e-05	0.00143	CbGpPWpGaD
Rosuvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.22e-05	0.00143	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.19e-05	0.00142	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.19e-05	0.00142	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.19e-05	0.00142	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.19e-05	0.00142	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.17e-05	0.00142	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.14e-05	0.00141	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.07e-05	0.00138	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.05e-05	0.00138	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.04e-05	0.00137	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.04e-05	0.00137	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	4.02e-05	0.00137	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.02e-05	0.00136	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.02e-05	0.00136	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.98e-05	0.00135	CbGpPWpGaD
Rosuvastatin—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.92e-05	0.00133	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.92e-05	0.00133	CbGpPWpGaD
Rosuvastatin—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	3.89e-05	0.00132	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.87e-05	0.00131	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.85e-05	0.00131	CbGpPWpGaD
Rosuvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.85e-05	0.00131	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.84e-05	0.0013	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.83e-05	0.0013	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.82e-05	0.00129	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.81e-05	0.00129	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.8e-05	0.00129	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.77e-05	0.00128	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.72e-05	0.00126	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.72e-05	0.00126	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	3.71e-05	0.00126	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	3.69e-05	0.00125	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CHAT—amyotrophic lateral sclerosis	3.64e-05	0.00124	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.62e-05	0.00123	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.58e-05	0.00121	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.57e-05	0.00121	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PLB1—amyotrophic lateral sclerosis	3.48e-05	0.00118	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	3.45e-05	0.00117	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	3.45e-05	0.00117	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	3.41e-05	0.00116	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	3.35e-05	0.00114	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.35e-05	0.00114	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.32e-05	0.00113	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.31e-05	0.00112	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.27e-05	0.00111	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.23e-05	0.00109	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GSR—amyotrophic lateral sclerosis	3.21e-05	0.00109	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.18e-05	0.00108	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	3.12e-05	0.00106	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	3.12e-05	0.00106	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.00105	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	3.03e-05	0.00103	CbGpPWpGaD
Rosuvastatin—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.03e-05	0.00103	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	3.02e-05	0.00102	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	3e-05	0.00102	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	3e-05	0.00102	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	2.99e-05	0.00101	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.00101	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000992	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.9e-05	0.000985	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.89e-05	0.000982	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.86e-05	0.00097	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	2.83e-05	0.000961	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.00095	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	2.78e-05	0.000943	CbGpPWpGaD
Rosuvastatin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.76e-05	0.000938	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.75e-05	0.000933	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.73e-05	0.000925	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.7e-05	0.000916	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.68e-05	0.000909	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CHAT—amyotrophic lateral sclerosis	2.63e-05	0.000894	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.61e-05	0.000886	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.61e-05	0.000884	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.6e-05	0.000883	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	2.59e-05	0.000878	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	2.59e-05	0.000878	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.55e-05	0.000867	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.55e-05	0.000867	CbGpPWpGaD
Rosuvastatin—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	2.54e-05	0.000863	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000862	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.49e-05	0.000846	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.48e-05	0.000842	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	0.000828	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	2.42e-05	0.000822	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.41e-05	0.000819	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	2.41e-05	0.000818	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.4e-05	0.000816	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.4e-05	0.000815	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	2.37e-05	0.000803	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.32e-05	0.000788	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.32e-05	0.000788	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.3e-05	0.00078	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.29e-05	0.000779	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.29e-05	0.000779	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.29e-05	0.000777	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.28e-05	0.000773	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	2.24e-05	0.00076	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.2e-05	0.000747	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.000746	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.19e-05	0.000745	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.17e-05	0.000737	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.17e-05	0.000735	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.12e-05	0.000721	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.12e-05	0.00072	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.12e-05	0.000719	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.12e-05	0.000719	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	0.000708	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.07e-05	0.000702	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.04e-05	0.000694	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.01e-05	0.000681	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	1.99e-05	0.000677	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.98e-05	0.000672	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.98e-05	0.00067	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.97e-05	0.00067	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.97e-05	0.000667	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TP53—amyotrophic lateral sclerosis	1.97e-05	0.000667	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	0.000665	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.94e-05	0.000657	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.88e-05	0.000638	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	1.87e-05	0.000635	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.86e-05	0.00063	CbGpPWpGaD
Rosuvastatin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.82e-05	0.000619	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.81e-05	0.000613	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.8e-05	0.000611	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000611	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.8e-05	0.00061	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.75e-05	0.000594	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.74e-05	0.000591	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	1.73e-05	0.000586	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000582	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.69e-05	0.000575	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.68e-05	0.00057	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.65e-05	0.000559	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.65e-05	0.000559	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.53e-05	0.00052	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.52e-05	0.000516	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000511	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000503	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.46e-05	0.000495	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	1.45e-05	0.000492	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.42e-05	0.000481	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.42e-05	0.000481	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.4e-05	0.000474	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.4e-05	0.000474	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000469	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.38e-05	0.000467	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	0.000444	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.31e-05	0.000444	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.3e-05	0.000442	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.28e-05	0.000436	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.28e-05	0.000434	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.27e-05	0.000432	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.25e-05	0.000423	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.24e-05	0.000421	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.24e-05	0.00042	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.19e-05	0.000404	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.19e-05	0.000403	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.000401	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000399	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000399	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.16e-05	0.000394	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000386	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.13e-05	0.000383	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.12e-05	0.000379	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000369	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.000365	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.07e-05	0.000363	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	1.07e-05	0.000363	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.000363	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.06e-05	0.000361	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	0.000344	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.01e-05	0.000343	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.01e-05	0.000343	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.8e-06	0.000333	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.77e-06	0.000332	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.75e-06	0.000331	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	9.71e-06	0.000329	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.65e-06	0.000327	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	9.6e-06	0.000326	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.36e-06	0.000318	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.29e-06	0.000315	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	8.94e-06	0.000303	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	8.9e-06	0.000302	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.8e-06	0.000299	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.8e-06	0.000298	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.6e-06	0.000292	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	8.04e-06	0.000273	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.03e-06	0.000272	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.79e-06	0.000265	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.65e-06	0.00026	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	7.64e-06	0.000259	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.34e-06	0.000249	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	7.08e-06	0.00024	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.06e-06	0.00024	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.72e-06	0.000228	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.71e-06	0.000228	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	6.58e-06	0.000223	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.16e-06	0.000209	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.12e-06	0.000208	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.03e-06	0.000205	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.81e-06	0.000197	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.8e-06	0.000197	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.78e-06	0.000196	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.51e-06	0.000187	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.5e-06	0.000187	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.31e-06	0.00018	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.24e-06	0.000178	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.18e-06	0.000176	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	5.07e-06	0.000172	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.85e-06	0.000165	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.76e-06	0.000162	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.73e-06	0.00016	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.39e-06	0.000149	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.37e-06	0.000148	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.34e-06	0.000147	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.92e-06	0.000133	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.57e-06	0.000121	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.47e-06	0.000118	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.12e-06	0.000106	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.99e-06	0.000102	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.86e-06	9.72e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.69e-06	9.12e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.45e-06	8.31e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.36e-06	8e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.62e-06	5.48e-05	CbGpPWpGaD
